methamphetamine has been researched along with Anxiety in 108 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (9.26) | 18.7374 |
| 1990's | 6 (5.56) | 18.2507 |
| 2000's | 18 (16.67) | 29.6817 |
| 2010's | 56 (51.85) | 24.3611 |
| 2020's | 18 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agius, PA; Dietze, P; Duncan, Z; Kippen, R; Quinn, B; Sutton, K; Ward, B | 1 |
| Chen, CY; Ding, Y; Li, P; Sun, YZ; Yang, XG; Yu, TY | 1 |
| Bai, L; Chen, F; Chen, M; Du, Y; Duan, Y; Gao, J; Kuang, YQ; Ma, Y; Peng, Q; Shi, K; Tian, W; Wang, H; Wang, K; Wu, H; Xie, Z; Xiong, P; Xu, Y; Yang, J; Yu, J; Zhang, Y; Zhang, Z; Zhou, Y; Zhu, M; Zhu, T | 1 |
| Gao, Z; Lai, M; Li, J; Luo, D; Shen, D; Tan, L; Xu, J; Yu, L | 1 |
| Tang, Z; Xu, J; Zhu, Z | 1 |
| Apostolopoulos, V; Davidson, M; Filippone, RT; Fraser, S; Habib, A; Mathai, ML; Mayer, M; Nurgali, K; Prakash, MD; Rashidi, N; Sinnayah, P; Tangalakis, K | 1 |
| de Andrade, D; Dingle, G; Haslam, C; Hides, L; Quinn, CA; Walter, ZC | 1 |
| Fan, Y; Ge, F; Guan, X; He, T; Li, N; Lu, X; Wang, Z; Wen, J; Xu, B; Xu, X; Yang, P | 1 |
| Chen, LJ; Ding, JF; He, JT; Li, JH; Li, XW; Liu, JL; Liu, Y; Wang, Q; Xie, XL; Yang, JZ; Zhang, KK; Zhao, D | 1 |
| Du, D; Fan, Y; Ge, F; Guan, X; Lu, X; Pan, W; Peng, Y; Song, H; Xu, X; Yang, X | 1 |
| Rauhut, AS | 1 |
| Apicco, DJ; Ash, PEA; Beierle, JA; Blum, BC; Bryant, CD; Cheung, J; Coelho, MA; Emili, A; Fultz, EK; Healy, AF; Kandola, AK; Lin, W; Luttik, KP; Mortazavi, F; Ragu Varman, D; Ramamoorthy, S; Rosene, DL; Ruan, QT; Shahin, JR; Smith, NJ; Szumlinski, KK; Wolozin, B; Yazdani, N; Zheng, K | 1 |
| Baracz, SJ; Cornish, JL; Everett, NA | 1 |
| Madden, JT; Pentkowski, NS; Reyna, NC | 1 |
| Forouzan, S; Hoffman, KL; Kosten, TA | 1 |
| Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR | 1 |
| Akbarnejad, Z; Asadi-Shekaari, M; Esmaeilpour, K; Ghazvini, H; Khodamoradi, M; Rafaiee, R; Seyedhosseini Tamijani, SM; Sheibani, V; Tirgar, F | 1 |
| Acevedo, J; Newby, ML; Ortman, HA; Siegel, JA | 1 |
| Gong, Q; Huang, X; Jiang, P; Kendrick, K; Li, J; Li, L; Lu, L; Sun, J; Zhou, X | 1 |
| Bujarski, S; Courtney, KE; London, ED; Ray, LA; Roche, DJO; Shoptaw, S; Worley, MJ | 1 |
| He, J; Ren, W; Su, H; Tao, J; Xie, Y; Zhang, J; Zhang, X | 1 |
| Hicks, C; Liu-Chen, LY; Philogene-Khalid, HL; Rawls, SM; Reitz, AB | 1 |
| Asadbegi, M; Etaee, F; Komaki, A; Sarihi, A; Shahidi, S; Soleimani Asl, S; Taslimi, Z | 1 |
| Gouzoulis-Mayfrank, E; Hamdorf, W; Härtel-Petri, R; Havemann-Reinecke, U; Mühlig, S; Wodarz, N | 1 |
| Ahmadiani, A; Beirami, E; Dargahi, L; Oryan, S; Seyedhosseini Tamijani, SM | 1 |
| Ahmadiani, A; Beirami, E; Dargahi, L; Seyedhosseini Tamijani, SM | 1 |
| Kirby, LG; Nayak, S; Rawls, SM; Reitz, AB; Tallarida, C; Yu, F; Zewde, AM | 1 |
| Ahmadi-Zeidabadi, M; Arjmand, S; Khaksari, M; Ramshini, E; Sepehri, G; Shabani, M | 1 |
| Huang, ET; Huckans, M; Hudson, R; Loftis, JM; Phillips, TJ; Wilhelm, CJ | 1 |
| Hamilton, JJ; Hughes, RN | 1 |
| Siegel, JA; Struntz, KH | 1 |
| Baker, EP; Dahly, AM; Magnuson, EC; Siegel, JA | 1 |
| Alger, JR; Johnson, MC; London, ED; O'Neill, J; Shen, Z; Tang, J | 1 |
| Boyette-Davis, JA; Gonzalez, CMF; Guarraci, FA; Kunkel, MN; Lucero, DA; Rice, HR; Shoubaki, RI; Womble, PD | 1 |
| Hou, W; Tao, Y; Yu, L; Zeng, L; Zong, L | 1 |
| Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T | 1 |
| Chen, L; Li, C; Li, Y; Ru, Q; Tian, X; Xiao, H; Xiong, Q; Zhou, M | 1 |
| Akita, H; Ishibashi, H; Ogata, M | 1 |
| Karami, L; Kermanshahi, S; Keshavarzi, S; Motaghinejad, M; Motevalian, M; Sadr, S | 1 |
| Brooks, ML; Jacobskind, JS; Rosinger, ZJ; Zuloaga, DG | 1 |
| Alavijeh, MM; Hojati, V; Khaksari, M; Vaezi, G | 1 |
| Huang, Z; Li, J; Lin, Z; Rao, Y; Tao, X; Wang, H; Zhang, Y; Zheng, S | 1 |
| Brecht, ML; Herbeck, DM | 1 |
| Blake, B; Cloutier, RL; Fu, RR; Hendrickson, RG | 1 |
| Blanco, C; Jin, CJ; Kerridge, B; Rafful, C; Schwartz, RP; Wall, MM | 1 |
| Mohammad, A; Ramroop, J; Shen, H; Smith, SS | 1 |
| Deng, Y; Han, M; Li, Y; Liu, C; Liu, X; Lv, R; Robert Brašić, J; Wang, Y; Yuan, J; Zhang, G | 1 |
| Davenport, PW; May, AC; Paulus, MP; Poppa, T; Stewart, JL; Tapert, SF | 1 |
| Bigdeli, I; Hajheidari, S; Miladi-Gorji, H | 2 |
| Biala, G; Boguszewska-Czubara, A; Budzynska, B; Kruk-Slomka, M; Kurzepa, J | 1 |
| Ang, A; Chudzynski, J; Cooper, CB; Dickerson, D; Dolezal, B; Gonzales, R; Mooney, L; Rawson, RA | 1 |
| Forster, SL; Fulde, GW | 1 |
| Chua, BE; Gundlach, AL; Haidar, M; Lam, M; Smith, CM | 1 |
| Macúchová, E; Nohejlová, K; Pometlová, M; Šlamberová, R; Stuchlík, A; Valeš, K | 1 |
| Kim, JH; Liu, Y; Qiu, Y; Shen, HW; Xu, P; Zhang, Y; Βai, Y | 1 |
| Bailey, A; Garcia-Carmona, JA; Georgiou, P; Hourani, S; Kitchen, I; Laorden, ML; Zanos, P | 1 |
| Hrebíčková, I; Macúchová, E; Nohejlová, K; Ševčíková, M; Šlamberová, R | 1 |
| De La Garza, R; Grasing, K; Haile, CN; Kosten, TR; Newton, TF; Verrico, CD | 1 |
| Jones, L; Parrott, A; Reed, P | 1 |
| Do, TN; Rud, MA; Siegel, JA | 1 |
| Arnold, TC; Horowitz, BZ; Lange, RA; Richards, JR | 1 |
| Canales, JJ; Loxton, D | 1 |
| Cho, J; Delis, F; Kim, R; Rocco, MJ; Thanos, PK; Volkow, ND | 1 |
| Biała, G; Budzynska, B; Frankowska, M; Kaszubska, K; Michalak, A | 1 |
| Buck, JM; Morris, AS; Raber, J; Siegel, JA; Weber, SJ | 1 |
| Carrico, AW; Chesney, MA; Johnson, MO; Morin, SF | 1 |
| Herbert, CE; Hughes, RN | 1 |
| Hrubá, L; Pometlová, M; Rokyta, R; Schutová, B; Slamberová, R | 1 |
| Hain, JD; Smith, BM; Stevenson, I | 1 |
| Kitanaka, J; Kitanaka, N; Morita, Y; Nishiyama, N; Takemura, M; Tanaka, K; Tatsuta, T; Watabe, K | 1 |
| Aitchison, KJ; Malhotra, AK | 1 |
| Feldman, Z; Gentry, BW; Mancino, MJ; Mendelson, J; Oliveto, A | 1 |
| Ali, R; Arunpongpaisal, S; Kongsakon, R; Marsden, J; Srisurapanont, M; Wada, K | 1 |
| Andoh, H; Byrne, DW; Hashimoto, A; Kawaguchi, M; Kobayashi, H; Shinomiya, T; Tamaki, R; Yoshikawa, M | 1 |
| Byrne, DW; Hashimoto, A; Kawaguchi, M; Kobayashi, H; Shinomiya, T; Tamaki, R; Yoshikawa, M | 1 |
| McQuaid, JR; Patterson, TL; Semple, SJ; Strathdee, SA; Zians, J | 1 |
| Hrubá, L; Schutová, B; Šlamberová, R | 1 |
| den Hollander, B; Korpi, ER; Linden, AM; Ojanperä, I; Rozov, S; Uusi-Oukari, M | 1 |
| de Wit, H; Nikolayev, L; Söderpalm, A | 1 |
| Li, X; Liu, W; Liu, YL; Song, M; Wang, JH; Wu, CF; Yang, JY | 1 |
| Berman, SM; Bramen, J; Dong, Y; Kurian, V; Learn, J; Lichtman, AM; Ling, W; London, ED; Mandelkern, MA; Matochik, JA; Miotto, K; Newton, T; Rawson, R; Shinn, AK; Simon, SL; Woods, R | 1 |
| Hayase, T; Yamamoto, K; Yamamoto, Y | 3 |
| Clemens, KJ; Cornish, JL; Hunt, GE; Li, KM; McGregor, IS; Van Nieuwenhuyzen, PS | 1 |
| Clemens, KJ; Cornish, JL; Hunt, GE; McGregor, IS | 1 |
| Ehrman, LA; Fienberg, AA; Greengard, P; Gudelsky, GA; Reed, TM; Schaefer, TL; Vorhees, CV; Williams, MT | 1 |
| Akiyama, K | 1 |
| Ago, Y; Baba, A; Hashimoto, H; Matsuda, T; Nakamura, S; Takahashi, K | 1 |
| Chapin, DS; Harms, JF; Martin, AN; McCarthy, SA; Schmidt, CJ; Siuciak, JA | 1 |
| Fair, AD; Gortmaker, S; Hobson, J; Koenen, K; Mayer, KH; Mimiaga, MJ; Safren, SA; Tetu, AM | 1 |
| Babbini, M; Cestari, A; De Marchi, F; Graziani, G | 1 |
| Matsuda, H; Matsumoto, K; Osanai, M; Shimada, T; Terasawa, K; Watanabe, H | 1 |
| Groen, B; Philippens, IH; Wolthuis, OL | 1 |
| Goto, K; Ikemoto, S; Ishiguro, T; Yui, K | 4 |
| Yamamoto, J | 1 |
| Morgan, RT; Young, GC | 1 |
| Buckman, J; Hain, JD; Smith, BM; Stevenson, I | 1 |
| Barnett, A; Roth, FE; Taber, RI | 1 |
| Milkovich, L; van den Berg, BJ | 1 |
| Brown, AR; Halikas, JA; Levy, RM | 1 |
| Johnson, FG | 1 |
| Fischer, CM; Smith, DE | 1 |
| Irwin, S; Kinohi, RG; Van Sloten, M | 1 |
2 review(s) available for methamphetamine and Anxiety
| Article | Year |
|---|---|
Psychological Effects of Repetitive Transcranial Magnetic Stimulation on Individuals With Methamphetamine Use Disorder: A Systematic Review and Meta-Analysis.
Topics: Anxiety; China; Cognition; Humans; Methamphetamine; Randomized Controlled Trials as Topic; Transcranial Magnetic Stimulation | 2023 |
The impact of amphetamine-type stimulants on emergency services.
Topics: Acute Disease; Aggression; Amphetamine; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Delusions; Depression; Drug Overdose; Emergency Service, Hospital; Hallucinations; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paranoid Disorders; Sleep Initiation and Maintenance Disorders; Suicidal Ideation | 2015 |
10 trial(s) available for methamphetamine and Anxiety
| Article | Year |
|---|---|
[Effect of
Topics: Acupuncture Points; Acupuncture Therapy; Anxiety; Humans; Methamphetamine; Quality of Life | 2022 |
Controlled Trial Examining the Strength-Based Grit Wellbeing and Self-Regulation Program for Young People in Residential Settings for Substance Use.
Topics: Adolescent; Anxiety; Cannabis; Female; Humans; Male; Methamphetamine; Residential Treatment; Self-Control; Substance-Related Disorders | 2022 |
Electro-acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence: A randomized controlled trial.
Topics: Acupuncture Points; Adult; Anxiety; China; Depression; Electroacupuncture; Female; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Single-Blind Method; Substance Withdrawal Syndrome | 2018 |
The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Depression; Exercise Therapy; Female; Humans; Male; Methamphetamine; Middle Aged; Residential Treatment; Young Adult | 2015 |
Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.
Topics: Administration, Intravenous; Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Anxiety; Blood Pressure; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Users; Female; Healthy Volunteers; Heart Rate; Humans; Male; Methamphetamine; Middle Aged; Perindopril; Young Adult | 2016 |
Effectiveness and processes of interviewing with drugs.
Topics: Amobarbital; Anxiety; Attention; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Interviews as Topic; Male; Methamphetamine; Placebos; Pregnanediones; Research Design; Speech; Substance-Related Disorders | 1966 |
Effects of stress on responses to methamphetamine in humans.
Topics: Adolescent; Adult; Affect; Analysis of Variance; Anxiety; Blood Pressure; Central Nervous System Stimulants; Corticosterone; Demography; Fatigue; Heart Rate; Humans; Male; Methamphetamine; Pain Measurement; Personality Inventory; Radioimmunoassay; Stress, Physiological; Surveys and Questionnaires; Time Factors | 2003 |
Monoamine neurotransmitter metabolites and spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Anxiety; Biogenic Monoamines; Female; Humans; Methamphetamine; Psychological Tests; Psychoses, Substance-Induced; Recurrence; Stress, Psychological | 1997 |
Precipitating factors in spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Anxiety; Biogenic Monoamines; Dopamine Uptake Inhibitors; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Recurrence; Stress, Psychological; Substance-Related Disorders | 1997 |
Controlled interviews using drugs. II. Comparisons between restricted and freer conditions.
Topics: Adult; Amobarbital; Anger; Anxiety; Attitude of Health Personnel; Attitude to Health; Clinical Trials as Topic; Emotions; Female; Humans; Interview, Psychological; Male; Memory; Mental Disorders; Methamphetamine; Physician-Patient Relations; Placebos; Pregnanediones; Self Concept; Speech; Surveys and Questionnaires; Time Factors | 1973 |
96 other study(ies) available for methamphetamine and Anxiety
| Article | Year |
|---|---|
Correlates of anxiety and depression in a community cohort of people who smoke methamphetamine.
Topics: Anxiety; Anxiety Disorders; Depression; Female; Humans; Male; Methamphetamine; Native Hawaiian or Other Pacific Islander; Prospective Studies; Smoking; Victoria | 2022 |
Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Depression; Inosine; Metformin; Methamphetamine; Mice; Microbiota; Rats; Substance Withdrawal Syndrome | 2022 |
Characteristics of depression, anxiety, impulsivity, and aggression among various types of drug users and factors for developing severe depression: a cross-sectional study.
Topics: Adolescent; Adult; Aggression; Anxiety; Cross-Sectional Studies; Depression; Depressive Disorder, Major; Drug Users; Female; Heroin; Humans; Impulsive Behavior; Male; Methamphetamine; Substance-Related Disorders | 2022 |
Methamphetamine Induces Systemic Inflammation and Anxiety: The Role of the Gut-Immune-Brain Axis.
Topics: Albumins; Amphetamine-Related Disorders; Animals; Anxiety; Blood-Brain Barrier; Brain; Central Nervous System Stimulants; Epithelial Cell Adhesion Molecule; Inflammation; Methamphetamine; Mice | 2022 |
Specific Inhibition of Interpeduncular Nucleus GABAergic Neurons Alleviates Anxiety-Like Behaviors in Male Mice after Prolonged Abstinence from Methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; GABAergic Neurons; Interpeduncular Nucleus; Male; Methamphetamine; Mice; Substance Withdrawal Syndrome | 2023 |
Obeticholic acid protects against methamphetamine-induced anxiety-like behavior by ameliorating microbiota-mediated intestinal barrier impairment.
Topics: Animals; Anxiety; Methamphetamine; Mice; Microbiota; Neuroinflammatory Diseases | 2023 |
Gegen-Qinlian decoction-A traditional Chinese medicine formula-Alleviates methamphetamine withdrawal induced anxiety by targeting GABAergic interneuron-pyramidal neuron pathway in mPFC.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; gamma-Aminobutyric Acid; Interneurons; Medicine, Chinese Traditional; Methamphetamine; Mice; Pyramidal Cells; Substance Withdrawal Syndrome | 2023 |
Voluntary exercise ameliorates anxiogenic effects of acute methamphetamine exposure in Swiss-Webster mice.
Topics: Animals; Anxiety; Male; Methamphetamine; Mice; Motor Activity; Physical Conditioning, Animal | 2019 |
A Mutation in
Topics: Animals; Anxiety; Corpus Striatum; Dopamine; Dopaminergic Neurons; Exons; Exploratory Behavior; Female; Heterogeneous-Nuclear Ribonucleoprotein Group F-H; Heterogeneous-Nuclear Ribonucleoproteins; Heterozygote; Male; Mesencephalon; Methamphetamine; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; Mutation; Reflex, Startle; Reinforcement, Psychology; Reward; Rotarod Performance Test; Substance-Related Disorders; Synaptosomes | 2020 |
The effect of chronic oxytocin treatment during abstinence from methamphetamine self-administration on incubation of craving, reinstatement, and anxiety.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Craving; Dopamine Uptake Inhibitors; Extinction, Psychological; Female; Male; Methamphetamine; Oxytocics; Oxytocin; Pregnancy; Rats; Rats, Sprague-Dawley; Self Administration | 2020 |
Antagonizing serotonin 2A (5-HT
Topics: Animals; Anxiety; Behavior, Addictive; Central Nervous System Stimulants; Fluorobenzenes; Male; Methamphetamine; Piperidines; Rats; Reward; Serotonin; Serotonin Antagonists | 2020 |
Methamphetamine exposure and its cessation alter gut microbiota and induce depressive-like behavioral effects on rats.
Topics: Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Brain; Central Nervous System Stimulants; Depression; Dose-Response Relationship, Drug; Dysbiosis; Feces; Gastrointestinal Microbiome; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 16S; Swimming | 2021 |
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Depression; Disease Models, Animal; Endocannabinoids; Male; Methamphetamine; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substance Withdrawal Syndrome; TRPV Cation Channels | 2021 |
Ovarian hormones prevent methamphetamine-induced anxiety-related behaviors and neuronal damage in ovariectomized rats.
Topics: Animals; Anxiety; Brain; Central Nervous System Stimulants; Estrogens; Female; Methamphetamine; Neurons; Ovariectomy; Ovary; Progesterone; Rats; Rats, Wistar | 2021 |
The acute effects of multiple doses of methamphetamine on locomotor activity and anxiety-like behavior in adolescent and adult mice.
Topics: Age Factors; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Corticosterone; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred C57BL | 2021 |
Functional connectivity abnormalities underlying mood disturbances in male abstinent methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Cerebral Cortex; Connectome; Depression; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Nerve Net; Substance Withdrawal Syndrome; White Matter; Young Adult | 2021 |
Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.
Topics: Anxiety; Behavior, Addictive; Conditioning, Psychological; Craving; Cues; Data Collection; Double-Blind Method; Emotions; Humans; Methamphetamine; Naltrexone; Time Factors | 2017 |
Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Young Adult | 2017 |
Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.
Topics: Alkaloids; Animals; Anxiety; Anxiety Disorders; Central Nervous System Stimulants; Cocaine; Dopamine; Locomotion; Male; Methamphetamine; Rats; Reward; Stereoisomerism | 2017 |
The effects of methamphetamine and buprenorphine, and their interaction on anxiety-like behavior and locomotion in male rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Buprenorphine; Central Nervous System Stimulants; Drug Interactions; Male; Maze Learning; Methamphetamine; Motor Activity; Rats, Wistar | 2017 |
Methamphetamine-Related Disorders.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Anxiety; Germany; Humans; Methamphetamine; Randomized Controlled Trials as Topic | 2017 |
Intranasal insulin treatment alleviates methamphetamine induced anxiety-like behavior and neuroinflammation.
Topics: Administration, Intranasal; Animals; Anxiety; Blood Glucose; Brain; Cyclooxygenase 2; Encephalitis; Gliosis; Inflammation Mediators; Insulin; Male; Methamphetamine; NF-kappa B; Rats, Wistar | 2017 |
Effect of three different regimens of repeated methamphetamine on rats' cognitive performance.
Topics: Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Cognition; Drug Administration Schedule; Male; Maze Learning; Memory, Short-Term; Methamphetamine; Rats; Rats, Wistar; Recognition, Psychology | 2018 |
PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.
Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Benzodiazepines; Carbolines; Darkness; Dose-Response Relationship, Drug; Ethanol; Fluoxetine; Lighting; Methamphetamine; Models, Animal; Odorants; Olfactory Perception; Planarians; Predatory Behavior; Psychological Tests; Psychotropic Drugs; Spatial Behavior; Time Factors | 2018 |
Contribution of CB1Rs in anxiety-related behaviors but not locomotor deficits induced by methamphetamine.
Topics: Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Dopaminergic Neurons; Endocannabinoids; Methamphetamine; Motor Activity; Rats, Wistar | 2018 |
Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.
Topics: Adult; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Chemokine CCL3; Disease Models, Animal; Female; Follow-Up Studies; Genetic Predisposition to Disease; Hippocampus; Humans; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred DBA; Middle Aged; RNA, Messenger; Treatment Outcome | 2017 |
Sex-dependent modification by chronic caffeine of acute methamphetamine effects on anxiety-related behavior in rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Caffeine; Drug Administration Schedule; Drug Therapy, Combination; Female; Male; Maze Learning; Memory; Methamphetamine; Random Allocation; Rats; Sex Characteristics; Time Factors | 2018 |
Effects of methamphetamine exposure on anxiety-like behavior in the open field test, corticosterone, and hippocampal tyrosine hydroxylase in adolescent and adult mice.
Topics: Age Factors; Animals; Anxiety; Behavior, Animal; Brain; Central Nervous System Stimulants; Cognition; Corticosterone; Dopamine; Dopaminergic Neurons; Exploratory Behavior; Hippocampus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Tyrosine 3-Monooxygenase | 2018 |
The effects of enriched environment on the behavioral and corticosterone response to methamphetamine in adolescent and adult mice.
Topics: Age Factors; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Corticosterone; Depression; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Social Behavior; Social Environment; Social Isolation | 2018 |
N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Anxiety; Aspartic Acid; Central Nervous System Stimulants; Cerebral Cortex; Cross-Sectional Studies; Depression; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Middle Aged; Young Adult | 2019 |
A recreational dose of methylphenidate, but not methamphetamine, decreases anxiety-like behavior in female rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Illicit Drugs; Locomotion; Maze Learning; Methamphetamine; Methylphenidate; Rats; Rats, Long-Evans | 2018 |
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Topics: Amidohydrolases; Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Addictive; Behavior, Animal; Benzamides; Benzodioxoles; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Male; Maze Learning; Methamphetamine; Monoacylglycerol Lipases; Piperidines; Rats; Rats, Wistar | 2019 |
Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Depression; Disease Models, Animal; Hippocampus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Substance Withdrawal Syndrome | 2019 |
Behavioral responses to anxiogenic tasks in young adult rats with neonatal dopamine depletion.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Anxiety; Atomoxetine Hydrochloride; Behavior, Animal; Dopamine; Dopamine Uptake Inhibitors; Exploratory Behavior; Female; Lighting; Maze Learning; Methamphetamine; Motor Activity; Nerve Net; Oxidopamine; Pregnancy; Rats; Rats, Wistar | 2019 |
Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Depression; Glycogen Synthase Kinase 3; Hypoglycemic Agents; Male; Metformin; Methamphetamine; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2019 |
Stress-induced neural activation is altered during early withdrawal from chronic methamphetamine.
Topics: Animals; Anxiety; Brain; CA3 Region, Hippocampal; Central Nervous System Stimulants; Corticosterone; Depression; Exercise Test; Female; Hypothalamo-Hypophyseal System; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Stress, Physiological; Substance Withdrawal Syndrome; Swimming | 2019 |
Berberine hydrochloride attenuates voluntary methamphetamine consumption and anxiety-like behaviors via modulation of oxytocin receptors in methamphetamine addicted rats.
Topics: Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Berberine; Central Nervous System Stimulants; Drug-Seeking Behavior; Hippocampus; Locomotion; Methamphetamine; Nucleus Accumbens; Rats; Receptors, Oxytocin; Self Administration | 2019 |
Effects of N-ethylpentylone on locomotor activity and anxiety-like behavior in rats.
Topics: Alkaloids; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodioxoles; Butylamines; Locomotion; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley | 2019 |
Substance use and mental health characteristics associated with cognitive functioning among adults who use methamphetamine.
Topics: Adult; Aged; Anxiety; Central Nervous System Stimulants; Chronic Disease; Cognition Disorders; Depressive Disorder; Epidemiologic Methods; Female; Humans; Learning; Los Angeles; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Patient Acceptance of Health Care; Psychiatric Status Rating Scales; Psychomotor Performance; Substance-Related Disorders; Time Factors; Young Adult | 2013 |
Methamphetamine-related psychiatric visits to an urban academic emergency department: an observational study.
Topics: Adult; Age Factors; Amphetamine-Related Disorders; Anxiety; Chest Pain; Depression; Dyspnea; Emergency Service, Hospital; Emergency Services, Psychiatric; Female; Headache; Hospitals, University; Humans; Insurance, Health; Male; Mental Disorders; Methamphetamine; Middle Aged; Nausea; Psychoses, Substance-Induced; Seizures; Suicidal Ideation; Urban Health Services; Vomiting; Wounds and Injuries; Young Adult | 2013 |
The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study.
Topics: Adolescent; Alcoholism; Analgesics, Opioid; Anti-Anxiety Agents; Anxiety; Central Nervous System Stimulants; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hypnotics and Sedatives; Male; Methamphetamine; Pain; Pain Measurement; Prescription Drug Misuse; Substance-Related Disorders; United States; Young Adult | 2013 |
A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Gene Expression Regulation; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Pregnanolone; Rats; Rats, Long-Evans; Receptors, GABA-A; Sensory Gating; Stress, Psychological; Substance Withdrawal Syndrome | 2013 |
Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Asian People; Brain Mapping; Case-Control Studies; Corpus Striatum; Depression; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Organotechnetium Compounds; Time Factors; Tomography, Emission-Computed, Single-Photon | 2014 |
You are the danger: attenuated insula response in methamphetamine users during aversive interoceptive decision-making.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Brain Mapping; Cerebral Cortex; Decision Making; Drug Users; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Respiratory Rate; Reward; Uncertainty | 2014 |
Effect of the environmental enrichment on the severity of psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Depression; Environment; Male; Methamphetamine; Rats, Wistar; Substance Withdrawal Syndrome | 2015 |
Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models.
Topics: Animals; Anxiety; Drug Combinations; Illicit Drugs; Male; Maze Learning; Memory; Methamphetamine; Mice; Models, Animal; Motor Activity; Nicotine; Oxidative Stress | 2015 |
Sensitivity to Chronic Methamphetamine Administration and Withdrawal in Mice with Relaxin-3/RXFP3 Deficiency.
Topics: Anhedonia; Animals; Anxiety; Body Weight; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Exploratory Behavior; Methamphetamine; Mice; Mice, Knockout; Receptors, G-Protein-Coupled; Relaxin; Social Behavior; Substance Withdrawal Syndrome | 2016 |
Do the effects of prenatal exposure and acute treatment of methamphetamine on anxiety vary depending on the animal model used?
Topics: Animals; Anxiety; Disease Models, Animal; Female; Interpersonal Relations; Male; Methamphetamine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Vocalization, Animal | 2015 |
Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Depression; Environment; Exploratory Behavior; Male; Maze Learning; Methamphetamine; Motor Activity; Rats, Wistar; Stereotyped Behavior; Substance Withdrawal Syndrome | 2015 |
The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine.
Topics: Amphetamines; Animals; Anxiety; Central Nervous System Agents; Conditioning, Psychological; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; Propiophenones; Rats, Sprague-Dawley; Reward; Spatial Behavior; Substance Withdrawal Syndrome | 2016 |
Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
Topics: Amphetamine-Related Disorders; Amygdala; Animals; Anxiety; Central Nervous System Stimulants; Corpus Striatum; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Methamphetamine; Mice, Inbred C57BL; Neurons; Proto-Oncogene Proteins c-fos; Random Allocation; Receptors, Dopamine D2; Receptors, Opioid, mu; Receptors, Oxytocin; Septum of Brain; Substance Withdrawal Syndrome | 2016 |
How various drugs affect anxiety-related behavior in male and female rats prenatally exposed to methamphetamine.
Topics: Analgesics; Analysis of Variance; Animals; Anxiety; Central Nervous System Stimulants; Estrous Cycle; Exploratory Behavior; Female; Male; Maze Learning; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Serotonin Agents; Sex Factors; Time Factors | 2016 |
Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users.
Topics: Adult; Anger; Anxiety; Cross-Sectional Studies; Female; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sleep; Surveys and Questionnaires | 2016 |
Effects of early adolescent methamphetamine exposure on anxiety-like behavior and corticosterone levels in mice.
Topics: Age Factors; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Corticosterone; Male; Methamphetamine; Mice, Inbred C57BL; Motor Activity | 2016 |
Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amphetamine-Related Disorders; Anti-Anxiety Agents; Anxiety; Cardiovascular Diseases; Cardiovascular System; Central Nervous System Stimulants; Chest Pain; Cocaine; Cocaine-Related Disorders; Drug Interactions; Electrocardiography; Humans; Hyperhidrosis; Labetalol; Lorazepam; Male; Methamphetamine; Sodium Chloride; Tachycardia; Young Adult | 2017 |
Long-term cognitive, emotional and neurogenic alterations induced by alcohol and methamphetamine exposure in adolescent rats.
Topics: Animals; Anxiety; Central Nervous System Depressants; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Drug Combinations; Ethanol; Exploratory Behavior; Hippocampus; Immobility Response, Tonic; Male; Maze Learning; Methamphetamine; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Rats; Rats, Long-Evans; Statistics, Nonparametric; Time | 2017 |
Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain.
Topics: Animals; Anxiety; Benzazepines; Body Weight; Brain; Carbon Isotopes; Central Nervous System Stimulants; Cognition; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Exploratory Behavior; Male; Methamphetamine; Psychomotor Performance; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Recognition, Psychology; Signal Transduction; Spiperone | 2017 |
Acute behavioral effects of co-administration of mephedrone and MDMA in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Cognition; Depression; Disease Models, Animal; Drug Interactions; Male; Maze Learning; Memory; Methamphetamine; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Swimming | 2017 |
Effects of adolescent methamphetamine and nicotine exposure on behavioral performance and MAP-2 immunoreactivity in the nucleus accumbens of adolescent mice.
Topics: Animals; Anxiety; Cognition; Conditioning, Classical; Corticosterone; Male; Maze Learning; Methamphetamine; Mice, Inbred C57BL; Microtubule-Associated Proteins; Motor Activity; Nicotine; Nucleus Accumbens; Recognition, Psychology | 2017 |
Internalized heterosexism among HIV-positive, gay-identified men: implications for HIV prevention and care.
Topics: Adult; Amphetamine-Related Disorders; Anger; Anti-HIV Agents; Anxiety; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Comorbidity; Depression; Heterosexuality; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Internal-External Control; Male; Methamphetamine; Middle Aged; Patient Compliance; Prejudice; Self Concept; Sexual Behavior; Social Identification; Social Values; Stress, Psychological; Unsafe Sex | 2008 |
A comparison of 1-benzylpiperazine and methamphetamine in their acute effects on anxiety-related behavior of hooded rats.
Topics: Animals; Anxiety; Female; Male; Maze Learning; Methamphetamine; Piperazines; Rats; Stereotyped Behavior | 2009 |
Responsiveness to methamphetamine in adulthood is altered by prenatal exposure in rats.
Topics: Animals; Anxiety; Central Nervous System Stimulants; Exploratory Behavior; Female; Male; Maze Learning; Methamphetamine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar | 2010 |
Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Substance Withdrawal Syndrome | 2010 |
The Ninth Annual Pharmacogenetics in Psychiatry Meeting report.
Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety; Brain; Diffusion Tensor Imaging; Humans; Methamphetamine; Pharmacogenetics; Polymorphism, Single Nucleotide; Psychiatry; Randomized Controlled Trials as Topic; Substance-Related Disorders | 2011 |
Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study.
Topics: Adult; Affect; Amphetamine-Related Disorders; Anxiety; Blood Pressure; Cognition; Female; Heart Rate; Humans; Male; Methamphetamine; Middle Aged; Pilot Projects; Prospective Studies; Sleep; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Time Factors | 2011 |
Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
Topics: Adult; Affect; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Data Interpretation, Statistical; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Methamphetamine; Motivation; Outpatients; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Schizophrenic Psychology; Speech | 2011 |
Chronic administration of methamphetamine increases the mRNA expression of diazepam binding inhibitor in rat brain.
Topics: Animals; Anxiety; Brain; Carrier Proteins; Diazepam Binding Inhibitor; Injections, Intraperitoneal; Male; Methamphetamine; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Wistar; Receptors, GABA-A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2008 |
Acute administration of methamphetamine decreases the mRNA expression of diazepam binding inhibitor in rat brain.
Topics: Animals; Anxiety; Brain; Diazepam Binding Inhibitor; Dose-Response Relationship, Drug; Male; Maze Learning; Methamphetamine; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2008 |
Drug assertiveness and sexual risk-taking behavior in a sample of HIV-positive, methamphetamine-using men who have sex with men.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Assertiveness; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Risk-Taking; Safe Sex; Self Concept; Surveys and Questionnaires; Young Adult | 2011 |
Sex differences in anxiety-like behavior and locomotor activity following prenatal and postnatal methamphetamine exposure in adult rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anxiety; Disease Models, Animal; Dopamine Uptake Inhibitors; Estrous Cycle; Exploratory Behavior; Female; Immobility Response, Tonic; Male; Maternal Behavior; Maze Learning; Methamphetamine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Sex Characteristics; Video Recording | 2012 |
Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone.
Topics: Animals; Anxiety; Brain; Depression; Designer Drugs; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Hindlimb Suspension; Male; Maze Learning; Memory Disorders; Methamphetamine; Mice; Mice, Inbred C57BL; Norepinephrine; Radioligand Assay; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2013 |
Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice.
Topics: Animals; Anxiety; Escape Reaction; Ginsenosides; Male; Maze Learning; Methamphetamine; Mice; Neuroprotective Agents; Plant Components, Aerial; Plant Extracts; Saponins | 2003 |
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Arousal; Attention; Blood Glucose; Brain; Brain Mapping; Depression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Methamphetamine; Neuropsychological Tests; Reference Values; Substance Withdrawal Syndrome; Tomography, Emission-Computed | 2004 |
Brain excitatory amino acid transporters (EAATs) and treatment of methamphetamine toxicity.
Topics: Amino Acid Transport System X-AG; Animals; Anxiety; Biological Transport; Brain; Cocaine; Dicarboxylic Acids; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acids; Glutamic Acid; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Neurotransmitter Uptake Inhibitors; Pyrrolidines; Stereotyped Behavior; Stress, Physiological | 2003 |
MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Topics: Animals; Anxiety; Behavior, Animal; Body Temperature; Corpus Striatum; Dopamine; Dopamine Agents; Drug Interactions; Fever; Hot Temperature; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Social Behavior | 2004 |
Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.
Topics: Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Cannabinoids; Cocaine; Cyclohexanols; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Endocannabinoids; Glycerides; Injections, Intraperitoneal; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred ICR; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Time Factors | 2005 |
Behavioral effects of ketamine and toxic interactions with psychostimulants.
Topics: Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Depression; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Ketamine; Lethal Dose 50; Locomotion; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred ICR; Models, Animal; Motor Activity; Receptors, N-Methyl-D-Aspartate; Seizures; Substance-Related Disorders; Swimming | 2006 |
Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Brain Chemistry; Drug Interactions; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Wistar; Serotonin; Social Behavior; Time | 2007 |
Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice.
Topics: Analysis of Variance; Animals; Anxiety; Central Nervous System Stimulants; Cyclic Nucleotide Phosphodiesterases, Type 1; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Hyperkinesis; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phosphoric Diester Hydrolases; Signal Transduction; Spatial Behavior | 2006 |
Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Brief Psychiatric Rating Scale; Depression; Dopamine Agents; Female; Humans; Longitudinal Studies; Methamphetamine | 2006 |
Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Carbolines; Central Nervous System Stimulants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; GABA Antagonists; GABA Modulators; Male; Methamphetamine; Mice; Motor Activity; Phenobarbital; Social Isolation | 2007 |
Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background.
Topics: Amphetamine; Animals; Anxiety; Avoidance Learning; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Chromatography, High Pressure Liquid; Depression; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Hot Temperature; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nucleotides, Cyclic; Pain Measurement; Phencyclidine; Phosphoproteins; Phosphoric Diester Hydrolases; Serotonin; Swimming | 2008 |
Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use.
Topics: Adult; Anxiety; Central Nervous System Stimulants; Depression; HIV Infections; Homosexuality, Male; Humans; Internet; Interviews as Topic; Male; Massachusetts; Methamphetamine; Middle Aged; Persuasive Communication; Risk Factors; Risk-Taking; Self Disclosure; Substance-Related Disorders | 2008 |
Central nervous system activity of 1-(3-methoxypropylamino)-2-hydroxy-2-(1,4-benzodioxan-2-yl)-ethane hydrochloride.
Topics: Animals; Anxiety; Behavior, Animal; Caffeine; Central Nervous System; Chlorpromazine; Desipramine; Drug Synergism; Electroencephalography; Humans; Methamphetamine; Phenelzine; Rats; Reserpine; Reticular Formation; Sympatholytics; Thiopental | 1967 |
The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Carbolines; Darkness; Light; Male; Methamphetamine; Mice; Motor Activity; Picrotoxin; Yohimbine | 1995 |
A simple automated test to measure exploratory and motor activity of marmosets.
Topics: Animals; Anxiety; Callithrix; Exploratory Behavior; Female; Male; Methamphetamine; Motor Activity; Pentobarbital; Psychological Tests; Psychopharmacology | 1994 |
Monoamine neurotransmitter function and spontaneous recurrence of methamphetamine psychosis.
Topics: Adult; Anxiety; Biogenic Monoamines; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Recurrence | 1996 |
Relationship between hippocampal theta-wave frequency and emotional behaviors in rabbits produced with stresses or psychotropic drugs.
Topics: Animals; Antipsychotic Agents; Anxiety; Central Nervous System Stimulants; Fear; Hippocampus; Methamphetamine; Psychomotor Performance; Rabbits; Reserpine; Rest; Stress, Physiological; Theta Rhythm; Wakefulness | 1998 |
Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.
Topics: Analysis of Variance; Anxiety; Biogenic Monoamines; Case-Control Studies; Central Nervous System Stimulants; Disease Susceptibility; Female; Humans; Methamphetamine; Psychoses, Substance-Induced; Secondary Prevention; Stress, Physiological | 2000 |
Rapidity of response to the treatment of enuresis.
Topics: Age Factors; Anxiety; Behavior Therapy; Child; Conditioning, Classical; Enuresis; Female; Humans; Imipramine; Male; Methamphetamine; Mother-Child Relations; Neurotic Disorders; Prognosis; Psychological Tests; Quaternary Ammonium Compounds; Socioeconomic Factors; Time Factors | 1973 |
Activity of antihistamines in laboratory antidepressant tests.
Topics: Amitriptyline; Animals; Anxiety; Blepharoptosis; Cyproheptadine; Drug Synergism; Histamine H1 Antagonists; Hostility; Humans; Hypothermia, Induced; Imipramine; Methamphetamine; Promethazine; Pyridines; Rats; Reserpine; Tetrabenazine; Tripelennamine | 1969 |
Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development.
Topics: Abnormalities, Drug-Induced; Aluminum; Anxiety; Child, Preschool; Chlordiazepoxide; Embryo, Mammalian; Female; Fetal Death; Fetus; Glutethimide; Humans; Hydrochlorothiazide; Hydroxides; Infant; Infant, Newborn; Magnesium; Meprobamate; Methamphetamine; Pentobarbital; Phenobarbital; Piperazines; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Vitamins | 1974 |
Illicit pentazocine (Talwin) use: a report of thirteen cases.
Topics: Adolescent; Adult; Amphetamine; Anxiety; Cannabis; Ethanol; Euphoria; Female; Heroin; Humans; Lysergic Acid Diethylamide; Male; Methamphetamine; Morphine; Pentazocine; Personality; Substance-Related Disorders | 1972 |
A comparison of short-term treatment effects of intravenous sodium amytal-methedrine and LSD in the alcoholic.
Topics: Affect; Alcoholism; Amobarbital; Anxiety; Canada; Depression; Hallucinations; Humans; Injections, Intravenous; Lysergic Acid Diethylamide; Methamphetamine; Professional-Patient Relations; Psychotherapy; Time Factors | 1970 |
An analysis of 310 cases of acute high-dose methamphetamine toxicity in Haight-Ashbury.
Topics: Anxiety; Drug Tolerance; Fatigue; Gastrointestinal Diseases; Hepatitis; Humans; Injections, Intravenous; Methamphetamine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Substance-Related Disorders | 1970 |
Drug effects on the foot shock-induced behavior of paired mice.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Electroshock; Foot; Hostility; Humans; Hypnotics and Sedatives; Methadone; Methamphetamine; Tranquilizing Agents | 1968 |